About
MD and PhD chemist from KU Leuven whose team developed t-PA; founder and former chairman of ThromboGenics and recipient of the Francqui Prize.
Experience
- ThromboGenicsOwner
Colleagues at Fund+
Frequently asked questions
- Where does Désiré Collen work?
- Désiré Collen is Honorary Chairman / Board Observer at Fund+.








